BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23426167)

  • 1. The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells.
    Garnier N; Petruccelli LA; Molina MF; Kourelis M; Kwan S; Diaz Z; Schipper HM; Gupta A; del Rincon SV; Mann KK; Miller WH
    Leukemia; 2013 Nov; 27(11):2220-8. PubMed ID: 23426167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRG1 interacts with Nrf2 to selectively mediate HO-1 induction in response to oxidative stress.
    Zhang J; Ohta T; Maruyama A; Hosoya T; Nishikawa K; Maher JM; Shibahara S; Itoh K; Yamamoto M
    Mol Cell Biol; 2006 Nov; 26(21):7942-52. PubMed ID: 16923960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brg1-mediated Nrf2/HO-1 pathway activation alleviates hepatic ischemia-reperfusion injury.
    Ge M; Yao W; Yuan D; Zhou S; Chen X; Zhang Y; Li H; Xia Z; Hei Z
    Cell Death Dis; 2017 Jun; 8(6):e2841. PubMed ID: 28569786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propofol post-conditioning alleviates hepatic ischaemia reperfusion injury via BRG1-mediated Nrf2/HO-1 transcriptional activation in human and mice.
    Ge M; Chen H; Zhu Q; Cai J; Chen C; Yuan D; Jin Y; Yao W; Hei Z
    J Cell Mol Med; 2017 Dec; 21(12):3693-3704. PubMed ID: 28749008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of microRNA-199a-5p ameliorates oxygen-glucose deprivation/reoxygenation-induced apoptosis and oxidative stress in HT22 neurons by targeting Brg1 to activate Nrf2/HO-1 signalling.
    Li F; Liang J; Tong H; Zhu S; Tang D
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1020-1029. PubMed ID: 31990992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive oxygen species are not required for an arsenic trioxide-induced antioxidant response or apoptosis.
    Morales AA; Gutman D; Cejas PJ; Lee KP; Boise LH
    J Biol Chem; 2009 May; 284(19):12886-95. PubMed ID: 19279006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activating Nrf2 and Brg1.
    Li H; Yao W; Irwin MG; Wang T; Wang S; Zhang L; Xia Z
    Free Radic Biol Med; 2015 Jul; 84():311-321. PubMed ID: 25795513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brahma-related gene 1 ameliorates the neuronal apoptosis and oxidative stress induced by oxygen-glucose deprivation/reoxygenation through activation of Nrf2/HO-1 signaling.
    Li F; Liang J; Tang D
    Biomed Pharmacother; 2018 Dec; 108():1216-1224. PubMed ID: 30372823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brg1-dependent epigenetic control of vascular smooth muscle cell proliferation by hydrogen sulfide.
    Li L; Liu D; Bu D; Chen S; Wu J; Tang C; Du J; Jin H
    Biochim Biophys Acta; 2013 Jun; 1833(6):1347-55. PubMed ID: 23499876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2 Neh5 domain is differentially utilized in the transactivation of cytoprotective genes.
    Zhang J; Hosoya T; Maruyama A; Nishikawa K; Maher JM; Ohta T; Motohashi H; Fukamizu A; Shibahara S; Itoh K; Yamamoto M
    Biochem J; 2007 Jun; 404(3):459-66. PubMed ID: 17313370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of heme oxygenase-1 enhances anti-cancer effects of arsenic trioxide on glioma cells.
    Liu Y; Liang Y; Zheng T; Yang G; Zhang X; Sun Z; Shi C; Zhao S
    J Neurooncol; 2011 Sep; 104(2):449-58. PubMed ID: 21327864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes blocks the cardioprotective effects of sevoflurane postconditioning by impairing Nrf2/Brg1/HO-1 signaling.
    Gao S; Yang Z; Shi R; Xu D; Li H; Xia Z; Wu QP; Yao S; Wang T; Yuan S
    Eur J Pharmacol; 2016 May; 779():111-21. PubMed ID: 26973173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells.
    Valenzuela M; Glorieux C; Stockis J; Sid B; Sandoval JM; Felipe KB; Kviecinski MR; Verrax J; Buc Calderon P
    Br J Cancer; 2014 Aug; 111(5):874-82. PubMed ID: 25003661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic Trioxide Activate Transcription of Heme Oxygenase-1 by Promoting Nuclear Translocation of NFE2L2.
    Yue Z; Zhong L; Mou Y; Wang X; Zhang H; Wang Y; Xia J; Li R; Wang Z
    Int J Med Sci; 2015; 12(8):674-9. PubMed ID: 26283888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrf2-heme oxygenase-1 axis in mucoepidermoid carcinoma of the lung: Antitumoral effects associated with down-regulation of matrix metalloproteinases.
    Tertil M; Golda S; Skrzypek K; Florczyk U; Weglarczyk K; Kotlinowski J; Maleszewska M; Czauderna S; Pichon C; Kieda C; Jozkowicz A; Dulak J
    Free Radic Biol Med; 2015 Dec; 89():147-57. PubMed ID: 26393425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of heme oxygenase-1 by Brahma-related gene 1 through Nrf2 signaling confers protective effect against high glucose-induced oxidative damage of retinal ganglion cells.
    Sun W; Yu J; Kang Q
    Eur J Pharmacol; 2020 May; 875():173038. PubMed ID: 32105681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite effects of arsenic trioxide on the Nrf2 pathway in oral squamous cell carcinoma in vitro and in vivo.
    Zhang X; Su Y; Zhang M; Sun Z
    Cancer Lett; 2012 May; 318(1):93-8. PubMed ID: 22155346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docosahexaenoic acid (DHA)-induced heme oxygenase-1 attenuates cytotoxic effects of DHA in vascular smooth muscle cells.
    Stulnig G; Frisch MT; Crnkovic S; Stiegler P; Sereinigg M; Stacher E; Olschewski H; Olschewski A; Frank S
    Atherosclerosis; 2013 Oct; 230(2):406-13. PubMed ID: 24075775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9.
    Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; García-Marco JA; García-Pardo A
    Oncotarget; 2016 Dec; 7(50):83359-83377. PubMed ID: 27829220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders.
    Canestraro M; Galimberti S; Savli H; Palumbo GA; Tibullo D; Nagy B; Guerrini F; Piaggi S; Cine N; Metelli MR; Petrini M
    Cancer Genet Cytogenet; 2010 Jun; 199(2):110-20. PubMed ID: 20471514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.